...
机译:NAB-PACLITAXEL加吉西他滨的随机阶段2试验,有或没有Capecitabine和Cisplatin,在当地先进或临床可重型的胰腺癌腺癌
IRCCS Osped San Raffaele Dept Med Oncol Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Dept Med Oncol Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Pancreas Translat &
Clin Res Ctr Pancreat Surg Unit Via Olgettina 60;
IRCCS Osped San Raffaele Dept Radiotherapy Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Dept Med Oncol Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Dept Med Oncol Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Dept Med Oncol Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Dept Med Oncol Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Dept Radiol Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Pancreatobiliary Endoscopy &
Endosonog Div Via Olgettina 60 I-20132;
IRCCS Osped San Raffaele Dept Med Oncol Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Dept Med Oncol Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Pancreas Translat &
Clin Res Ctr Pancreat Surg Unit Via Olgettina 60;
IRCCS Osped San Raffaele Pathol Unit Via Olgettina 60 I-20132 Milan Italy;
IRCCS Osped San Raffaele Pancreas Translat &
Clin Res Ctr Pancreat Surg Unit Via Olgettina 60;
IRCCS Osped San Raffaele Pancreas Translat &
Clin Res Ctr Pancreat Surg Unit Via Olgettina 60;
IRCCS Osped San Raffaele Dept Med Oncol Via Olgettina 60 I-20132 Milan Italy;
Pancreatic cancer; Borderline resectable disease; Locally advanced disease; Chemotherapy; AG; PAXG;
机译:NAB-PACLITAXEL加吉西他滨的随机阶段2试验,有或没有Capecitabine和Cisplatin,在当地先进或临床可重型的胰腺癌腺癌
机译:吉西他滨/富紫外框的益处患者患者患者在FOLFIRINOX早期失败后濒临覆盖物可重演或局部晚期胰腺腺癌患者
机译:Neoadjuvant Nab-Paclitaxel和Gemcitabine在边缘地重新入住或局部先进的不可切除的胰腺腺癌,患者没有合适的Folfirinox
机译:与颅底可重型胰腺腺癌患者的痛苦治疗相比,胰腺切除术治疗中位生存率是否增加了胰腺的头部胰腺炎的患者?
机译:Nab-紫杉醇联合吉西他滨卡培他滨和顺铂(PAXG方案)在无法切除或边缘切除的胰腺腺癌患者的1B期临床试验
机译:β·吉西他滨,奥沙利铂和西妥昔单抗的第2阶段试验,然后选择基于Capecitabine的趋化学患者在临床中可重演或不可切除的局部晚期胰腺癌